MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Rituximab and Belimumab for Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE2
Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
Pilot Study of DRibble Vaccine for Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Vaccination of High Risk Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Adoptive Therapy Using Antigen-Specific CD4 T-Cells
- Status
- WITHDRAWN
- Phase
- PHASE1